APA (7th ed.) Citation

Wu, L., Lin, L., Yu, M., Li, H., Dang, Y., Liang, H., . . . Li, C. (2025). Antitumor Activity of USP7 Inhibitor GNE-6776 in Non-Small Cell Lung Cancer Involves Regulation of Epithelial-Mesenchymal Transition, Cell Cycle, Wnt/β-Catenin, and PI3K/AKT/mTOR Pathways. Pharmaceuticals (14248247), 18(2), 245. https://doi.org/10.3390/ph18020245

Chicago Style (17th ed.) Citation

Wu, Lipeng, et al. "Antitumor Activity of USP7 Inhibitor GNE-6776 in Non-Small Cell Lung Cancer Involves Regulation of Epithelial-Mesenchymal Transition, Cell Cycle, Wnt/β-Catenin, and PI3K/AKT/mTOR Pathways." Pharmaceuticals (14248247) 18, no. 2 (2025): 245. https://doi.org/10.3390/ph18020245.

MLA (9th ed.) Citation

Wu, Lipeng, et al. "Antitumor Activity of USP7 Inhibitor GNE-6776 in Non-Small Cell Lung Cancer Involves Regulation of Epithelial-Mesenchymal Transition, Cell Cycle, Wnt/β-Catenin, and PI3K/AKT/mTOR Pathways." Pharmaceuticals (14248247), vol. 18, no. 2, 2025, p. 245, https://doi.org/10.3390/ph18020245.